Medical Management for Adults with Prader

Abstract

Background:

Prader-Willi syndrome (PWS) is a genetic disorder characterized by morbid obesity resulting from insatiable appetite. Complications like diabetes mellitus or other cardiovascular diseases typically occur during lifetime. Lifestyle advice and education as well as limited caloric intake are the major concepts in assistance of PWS patients.

Methods:

A 12.9-month follow-up study, which included 8 formerly genetically diagnosed PWS patients, was conducted. Physical and laboratory examinations were done at the beginning and at the end of the follow-up. Improved medical care and lifestyle advice were given. The participants lived in an assisted living environment with a fixed daily schedule and limited caloric intake.

Results:

The group of patients consisted of manifest diabetics (n=6) as well as nondiabetics (n=2). Therapeutic concepts were simplified in 2 patients by switching from insulin to oral antidiabetics. The reduction in body weight was moderate, but attributable to a loss of fat mass. A significant reduction in blood cholesterol and triglyceride content was achieved along the observational period as well as a significant reduction of glycosylated hemoglobin (HbA1c) in the group of diabetic PWS patients. Systolic blood pressure improved during the study.

Conclusion:

A combination of an assisted living environment following conservative treatments as well as consistent patient care improved the daily and medical situation of PWS patients. Weight loss and, as a consequence, improvements in terms of metabolic condition and blood pressure were observed. A combination of medical and daily routine management should be established in PWS patients to improve their quality of life.

Get full access to this article

View all access options for this article.

References

Prader A

, Willi

. Ein Syndrom von Adipositas, Kleinwuchs, Kryptorchismus, und Oligophrenie nach myatonieartigem Zustand im Neugeborenenalter. Schweiz Med Wochenschr, 1956; 86:1260–1261.

Holm

, Cassidy

, Butler

et al. Prader-Willi syndrome: Consensus diagnostic criteria. Pediatrics, 1993; 91:398–402.

Bittel

, Butler

. Prader-Willi syndrome: Clinical genetics, cytogenetics and molecular biology. Expert Rev Mol Med, 2005; 7:1–20.

Laurance

, Brito

, Wilkinson

. Prader-Willi Syndrome after age 15 years. Arch Dis Child, 1981; 56:181–186.

Eiholzer

, Bachmann

, l'Allemand

. Is there growth hormone deficiency in Prader-Willi syndrome? Six arguments to support the presence of hypothalamic growth hormone deficiency in Prader-Willi syndrome. Horm Res, 2000; 53,Suppl 3:44–52.

Eldar-Geva

, Hirsch

, Benarroch

et al. Hypogonadism in females with Prader-Willi syndrome from infancy to adulthood: Variable combinations of a primary gonadal defect and hypothalamic dysfunction. Eur J Endocrinol, 2010; 162:377–384.

Radicioni

, Di Giorgio

, Grugni

et al. Multiple forms of hypogonadism of central, peripheral or combined origin in males with Prader–Willi syndrome. Clin Endocrinol (Oxf), 2012; 76:72–77.

Vaiani

, Herzovich

, Chaler

et al. Thyroid axis dysfunction in patients with Prader-Willi syndrome during the first 2 years of life. Clin Endocrinol (Oxf), 2010; 73:546–550.

Whittington

, Holland

, Webb

et al. Population prevalence and estimated birth incidence and mortality rate for people with Prader-Willi syndrome in one UK Health Region. J Med Genet, 2001; 38:792–798.

10.

Smith

, Loughnan

, Steinbeck

. Death in adults with Prader-Willi syndrome may be correlated with maternal uniparental disomy. J Med Genet, 2003; 40:e63.

11.

Illig

, Tschumi

, Vischer

. Glucose tolerance and diabetes mellitus in patients with Prader-Labhart-Willi syndrome. Mod Probl Pediatr, 1975; 12:203–210.

12.

Cyganek

, Koblik

, Kozek

et al. Liraglutide therapy in Prader-Willi syndrome. Diabet Med, 2010; 28:755–756.

Medical Management for Adults with Prader–Willi Syndrome